GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (XTER:PFE) » Definitions » Beneish M-Score
中文

Pfizer (XTER:PFE) Beneish M-Score

: -2.35 (As of Today)
View and export this data going back to 1996. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.35 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Pfizer's Beneish M-Score or its related term are showing as below:

XTER:PFE' s Beneish M-Score Range Over the Past 10 Years
Min: -2.64   Med: -2.47   Max: -2.06
Current: -2.35

During the past 13 years, the highest Beneish M-Score of Pfizer was -2.06. The lowest was -2.64. And the median was -2.47.


Pfizer Beneish M-Score Historical Data

The historical data trend for Pfizer's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.64 -2.42 -2.06 -2.33 -2.35

Pfizer Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.33 -2.40 -2.71 -2.74 -2.35

Competitive Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer Beneish M-Score Distribution

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Pfizer's Beneish M-Score falls into.



Pfizer Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Pfizer for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.7793+0.528 * 1.1502+0.404 * 1.1027+0.892 * 0.5695+0.115 * 0.9495
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.8424+4.679 * -0.021617-0.327 * 1.2731
=-2.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was €13,897 Mil.
Revenue was 13066.333 + 12398.384 + 11753.482 + 17075.388 = €54,294 Mil.
Gross Profit was 6131.062 + 3713.331 + 8765.731 + 12511.864 = €31,122 Mil.
Total Current Assets was €39,736 Mil.
Total Assets was €207,701 Mil.
Property, Plant and Equipment(Net PPE) was €17,368 Mil.
Depreciation, Depletion and Amortization(DDA) was €5,834 Mil.
Selling, General, & Admin. Expense(SGA) was €13,690 Mil.
Total Current Liabilities was €43,827 Mil.
Long-Term Debt & Capital Lease Obligation was €55,478 Mil.
Net Income was -3089.373 + -2231.934 + 2147.821 + 5177.162 = €2,004 Mil.
Non Operating Income was -1904.609 + 28.11 + 269.516 + 40.162 = €-1,567 Mil.
Cash Flow from Operations was 4805.08 + 3238.272 + -1114.984 + 1132.008 = €8,060 Mil.
Total Receivables was €13,715 Mil.
Revenue was 22929.76 + 22864.38 + 26243.932 + 23300.188 = €95,338 Mil.
Gross Profit was 13822.048 + 16740.75 + 18062.924 + 14234.716 = €62,860 Mil.
Total Current Assets was €48,388 Mil.
Total Assets was €186,162 Mil.
Property, Plant and Equipment(Net PPE) was €15,363 Mil.
Depreciation, Depletion and Amortization(DDA) was €4,818 Mil.
Selling, General, & Admin. Expense(SGA) was €13,048 Mil.
Total Current Liabilities was €39,778 Mil.
Long-Term Debt & Capital Lease Obligation was €30,137 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(13897.135 / 54293.587) / (13715.376 / 95338.26)
=0.255963 / 0.14386
=1.7793

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(62860.438 / 95338.26) / (31121.988 / 54293.587)
=0.659341 / 0.573217
=1.1502

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (39736.361 + 17367.98) / 207701.417) / (1 - (48388.496 + 15362.656) / 186161.52)
=0.725065 / 0.657549
=1.1027

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=54293.587 / 95338.26
=0.5695

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4818.112 / (4818.112 + 15362.656)) / (5833.847 / (5833.847 + 17367.98))
=0.238748 / 0.251439
=0.9495

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(13689.715 / 54293.587) / (13047.642 / 95338.26)
=0.252142 / 0.136856
=1.8424

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((55477.583 + 43827.098) / 207701.417) / ((30137.2 + 39778.272) / 186161.52)
=0.478113 / 0.375563
=1.2731

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2003.676 - -1566.821 - 8060.376) / 207701.417
=-0.021617

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Pfizer has a M-score of -2.37 suggests that the company is unlikely to be a manipulator.


Pfizer (XTER:PFE) Business Description

Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (XTER:PFE) Headlines

From GuruFocus

Pfizer Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at Citi BioPharma Conference Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc to Review Oral GLP-1 Data Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Pfizer Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at Wells Fargo Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Pfizer Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc's Dividend Analysis

By GuruFocus Research 01-24-2024